Manulife (Manufacturers Life Insurance)
DFTX

Manulife (Manufacturers Life Insurance)’s Definium Therapeutics DFTX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$499K Sell
26,404
-1,918
-7% -$32.5K ﹤0.01% 2159
2025
Q4 		$379K Buy
28,322
+3,004
+12% +$37.2K ﹤0.01% 2281
2025
Q3 		$298K Sell
25,318
-2,250
-8% -$21K ﹤0.01% 2395
2025
Q2 		$179K Buy
27,568
+204
+0.7% +$1.34K ﹤0.01% 2599
2025
Q1 		$160K Buy
27,364
+256
+0.9% +$1.83K ﹤0.01% 2565
2024
Q4 		$189K Buy
27,108
+503
+2% +$3.46K ﹤0.01% 2644
2024
Q3 		$151K Sell
26,605
-739
-3% -$5.14K ﹤0.01% 2754
2024
Q2 		$197K Buy
+27,344
New +$239K ﹤0.01% 2616
2022
Q2 		– Sell
-9,060
Closed -$151K – 3087
2022
Q1 		$151K Sell
9,060
-2,790
-24% -$48.4K ﹤0.01% 2865
2021
Q4 		$245 Buy
11,850
+114
+1% +$3.64K ﹤0.01% 2767
2021
Q3 		$537K Buy
11,736
+16
+0.1% +$692 ﹤0.01% 2238
2021
Q2 		$758K Buy
+11,720
New +$615K ﹤0.01% 2152

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s DFTX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Definium Therapeutics (DFTX) stake by 6.8% in Q1 2026, selling an estimated $32.5K and leaving 26,404 shares worth $499K. The position accounts for ﹤0.01% of the portfolio, ranked #2159.

Manulife (Manufacturers Life Insurance) first reported a position in DFTX in Q2 2021 and has held it in 12 quarters since. The position peaked at $758K in Q2 2021. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 26,404 shares of Definium Therapeutics worth $499K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,918 Definium Therapeutics shares in Q1 2026, an estimated $32.5K.
  • Definium Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2159 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Definium Therapeutics in Q2 2021 and has held it in 12 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Definium Therapeutics position peaked at $758K in Q2 2021.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.